Quotient Limited to Participate in the Cowen and Company 37th Annual Health Care Conference

JERSEY, Channel Islands, Feb. 22, 2017 -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the Cowen and Company 37^th Annual Health Care Conference on Wednesday, March 8, 2017 at 10:40 a.m. Eastern Time at the Boston Marriott Copley Place in Boston, MA. Also participating in the conference will be the Company’s Chief Financial Officer, Chris Lindop.

A webcast of the presentation will be available online from the investor relations page of the Company's corporate website at www.quotientbd.com. A webcast replay will be archived on the website for approximately 90 days.

About Quotient Limited

Quotient is a commercial-stage diagnostics company committed to reducing healthcare costs and improving patient care through the provision of innovative tests within established markets. With an initial focus on blood grouping and serological disease screening, Quotient is developing its proprietary MosaiQ™ technology platform to offer a breadth of tests that is unmatched by existing commercially available transfusion diagnostic instrument platforms. The company's operations are based in Edinburgh, Scotland; Eysins, Switzerland and Newtown, Pennsylvania.

The Quotient logo and MosaiQ™ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.

CONTACT:  Chris Lindop, Chief Financial Officer — 
[email protected]; +41 (0)799 61 69 38